Bradley J Phd Bolzon has an estimated net worth of $27 Million. This is based on reported shares across multiple companies, which include Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, HELICOS BIOSCIENCES CORP, Alexza Pharmaceuticals Inc., Flexion Therapeutics Inc, Monte Rosa Therapeutics, Inc., CRISPR Therapeutics AG, Black Diamond Therapeutics, Inc., NOVACEA INC, and PHASERX, INC..
2020 was Bradley J Phd Bolzon's most active year for acquiring shares with 20 total transactions. Bradley J Phd Bolzon's most active month to acquire stocks was the month of May. 2021 was Bradley J Phd Bolzon's most active year for disposing of shares, totalling 27 transactions. Bradley J Phd Bolzon's most active month to dispose stocks was the month of May. 2017 saw Bradley J Phd Bolzon paying a total of $0.00 for 55,447 shares, this is the most they've acquired in one year. In 2020 Bradley J Phd Bolzon cashed out on 340,648 shares for a total of $5,869,624.72, their largest year based on trade value.